• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Candida auris: an Emerging Fungal Pathogen.耳念珠菌:一种新兴的真菌病原体。
J Clin Microbiol. 2018 Jan 24;56(2). doi: 10.1128/JCM.01588-17. Print 2018 Feb.
2
Candida auris: Epidemiology, risk factors, virulence, resistance, and therapeutic options.耳念珠菌:流行病学、风险因素、毒力、耐药性和治疗选择。
Microb Pathog. 2018 Dec;125:116-121. doi: 10.1016/j.micpath.2018.09.014. Epub 2018 Sep 8.
3
Candida auris-the growing menace to global health.耳念珠菌——日益威胁全球健康的隐患。
Mycoses. 2019 Aug;62(8):620-637. doi: 10.1111/myc.12904. Epub 2019 Jun 18.
4
Candida auris: The recent emergence of a multidrug-resistant fungal pathogen.耳念珠菌:一种近期出现的多重耐药真菌病原体。
Med Mycol. 2019 Jan 1;57(1):1-12. doi: 10.1093/mmy/myy054.
5
Candida auris and Nosocomial Infection.耳念珠菌与医院感染。
Curr Drug Targets. 2020;21(4):365-373. doi: 10.2174/1389450120666190924155631.
6
Candida auris: a worrisome, globally emerging pathogen.耳念珠菌:一种令人担忧的、正在全球出现的病原体。
Expert Rev Anti Infect Ther. 2017 Sep;15(9):819-827. doi: 10.1080/14787210.2017.1364992. Epub 2017 Aug 14.
7
Are we ready for the global emergence of multidrug-resistant Candida auris in Taiwan?我们是否已准备好应对全球多重耐药性耳念珠菌在台湾的出现?
J Formos Med Assoc. 2018 Jun;117(6):462-470. doi: 10.1016/j.jfma.2017.10.005. Epub 2017 Nov 6.
8
Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses.全基因组测序和流行病学分析证实三大洲同时出现多重耐药性耳念珠菌
Clin Infect Dis. 2017 Jan 15;64(2):134-140. doi: 10.1093/cid/ciw691. Epub 2016 Oct 20.
9
Approach to the Investigation and Management of Patients With Candida auris, an Emerging Multidrug-Resistant Yeast.《耳念珠菌(一种新兴的耐多药酵母)患者的调查和管理方法》
Clin Infect Dis. 2018 Jan 6;66(2):306-311. doi: 10.1093/cid/cix744.
10
Candida auris: Epidemiology, biology, antifungal resistance, and virulence.耳念珠菌:流行病学、生物学、抗真菌耐药性和毒力。
PLoS Pathog. 2020 Oct 22;16(10):e1008921. doi: 10.1371/journal.ppat.1008921. eCollection 2020 Oct.

引用本文的文献

1
Prevalence, Microbiological Profile, and Risk Factors of Healthcare-Associated Infections in Intensive Care Units: A Retrospective Study in Aljouf, Saudi Arabia.重症监护病房中医疗相关感染的患病率、微生物学特征及危险因素:沙特阿拉伯朱夫省的一项回顾性研究
Microorganisms. 2025 Aug 17;13(8):1916. doi: 10.3390/microorganisms13081916.
2
infection at a pediatric burn center: Treatment and infection control measures.儿科烧伤中心的感染:治疗与感染控制措施
North Clin Istanb. 2025 Jun 11;12(3):285-289. doi: 10.14744/nci.2024.26429. eCollection 2025.
3
Diosgenin producing sp. strain IRMC27M2 as a genome-mined weapon against multidrug-resistant .产薯蓣皂苷元的菌株IRMC27M2作为对抗多重耐药性的基因组挖掘武器。
Comput Struct Biotechnol J. 2025 Jul 30;27:3410-3432. doi: 10.1016/j.csbj.2025.07.048. eCollection 2025.
4
Breaking down biofilms across critical priority fungal pathogens: proteomics and computational innovation for mechanistic insights and new target discovery.剖析关键优先真菌病原体中的生物膜:用于深入了解机制和发现新靶点的蛋白质组学与计算创新
mBio. 2025 Aug 13;16(8):e0230324. doi: 10.1128/mbio.02303-24. Epub 2025 Jul 22.
5
Managing Candida auris in dialysis units: challenges, strategies, and future directions.透析单位中耳念珠菌的管理:挑战、策略及未来方向。
Int Urol Nephrol. 2025 Jun 13. doi: 10.1007/s11255-025-04600-4.
6
Biofilm-Associated Candidiasis: Pathogenesis, Prevalence, Challenges and Therapeutic Options.生物膜相关性念珠菌病:发病机制、患病率、挑战与治疗选择
Pharmaceuticals (Basel). 2025 Mar 25;18(4):460. doi: 10.3390/ph18040460.
7
A Comprehensive Review of Candidemia and Invasive Candidiasis in Adults: Focus on the Emerging Multidrug-Resistant Fungus .成人念珠菌血症和侵袭性念珠菌病综合综述:聚焦新兴多重耐药真菌
Diseases. 2025 Mar 24;13(4):93. doi: 10.3390/diseases13040093.
8
Emergence and characterization of mixed Candida auris strain infections in China.中国耳念珠菌混合菌株感染的出现与特征
Infection. 2025 Apr 14. doi: 10.1007/s15010-025-02536-6.
9
Characterizing antimicrobial activity of environmental spp. and oral bacterial and fungal isolates from and .鉴定来自……的环境物种以及口腔细菌和真菌分离株的抗菌活性。 (注:原文中“and.”部分表述不完整,可能影响准确理解)
mSphere. 2025 May 27;10(5):e0009825. doi: 10.1128/msphere.00098-25. Epub 2025 Apr 14.
10
: A Continuing Threat.持续的威胁。
Microorganisms. 2025 Mar 13;13(3):652. doi: 10.3390/microorganisms13030652.

本文引用的文献

1
In vitro efficacy of disinfectants utilised for skin decolonisation and environmental decontamination during a hospital outbreak with Candida auris.在医院爆发耳念珠菌期间,用于皮肤去定植和环境消毒的消毒剂的体外功效。
Mycoses. 2017 Nov;60(11):758-763. doi: 10.1111/myc.12699. Epub 2017 Sep 15.
2
Yeasticidal activity of chemical disinfectants and antiseptics against Candida auris.化学消毒剂和防腐剂对耳念珠菌的杀酵母活性。
J Hosp Infect. 2017 Dec;97(4):371-375. doi: 10.1016/j.jhin.2017.08.019. Epub 2017 Sep 1.
3
Effectiveness of Disinfectants Against Candida auris and Other Candida Species.消毒剂对耳念珠菌和其他念珠菌属种的有效性。
Infect Control Hosp Epidemiol. 2017 Oct;38(10):1240-1243. doi: 10.1017/ice.2017.162. Epub 2017 Aug 10.
4
Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Health Care Surface.在塑料医疗保健表面上,新兴多药耐药病原性真菌假丝酵母菌的存活、持续存在和分离。
J Clin Microbiol. 2017 Oct;55(10):2996-3005. doi: 10.1128/JCM.00921-17. Epub 2017 Jul 26.
5
The first cases of Candida auris candidaemia in Oman.阿曼首例耳念珠菌血症病例。
Mycoses. 2017 Sep;60(9):569-575. doi: 10.1111/myc.12647. Epub 2017 Jul 7.
6
Rapid and Accurate Molecular Identification of the Emerging Multidrug-Resistant Pathogen Candida auris.新兴多重耐药病原体耳念珠菌的快速准确分子鉴定
J Clin Microbiol. 2017 Aug;55(8):2445-2452. doi: 10.1128/JCM.00630-17. Epub 2017 May 24.
7
Notes from the Field: Ongoing Transmission of Candida auris in Health Care Facilities - United States, June 2016-May 2017.实地记录:2016年6月至2017年5月美国医疗机构中耳念珠菌的持续传播
MMWR Morb Mortal Wkly Rep. 2017 May 19;66(19):514-515. doi: 10.15585/mmwr.mm6619a7.
8
Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values.八种抗真菌化合物对耳念珠菌的欧盟CAST和CLSI参考微量稀释法最低抑菌浓度比较及相关暂定流行病学截断值
Antimicrob Agents Chemother. 2017 May 24;61(6). doi: 10.1128/AAC.00485-17. Print 2017 Jun.
9
Simple low cost differentiation of Candida auris from Candida haemulonii complex using CHROMagar Candida medium supplemented with Pal's medium.使用补充了帕尔培养基的科玛嘉念珠菌培养基,简单低成本地区分耳念珠菌与哈氏念珠菌复合体。
Rev Iberoam Micol. 2017 Apr-Jun;34(2):109-111. doi: 10.1016/j.riam.2016.11.004. Epub 2017 Apr 6.
10
Candida auris candidaemia in Indian ICUs: analysis of risk factors.印度重症监护病房中的耳念珠菌血症:危险因素分析
J Antimicrob Chemother. 2017 Jun 1;72(6):1794-1801. doi: 10.1093/jac/dkx034.

耳念珠菌:一种新兴的真菌病原体。

Candida auris: an Emerging Fungal Pathogen.

机构信息

Department of Medicine, Division of Infectious Diseases, University of Utah, Salt Lake City, Utah, USA.

Department of Medicine, Division of Infectious Diseases, University of Utah, Salt Lake City, Utah, USA

出版信息

J Clin Microbiol. 2018 Jan 24;56(2). doi: 10.1128/JCM.01588-17. Print 2018 Feb.

DOI:10.1128/JCM.01588-17
PMID:29167291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5786713/
Abstract

has emerged globally as a multidrug-resistant health care-associated fungal pathogen. Recent reports highlight ongoing challenges due to organism misidentification, high rates of antifungal drug resistance, and significant patient mortality. The predilection for transmission within and between health care facilities possibly promoted by virulence factors that facilitate skin colonization and environmental persistence is unique among species. This minireview details the global emergence of and discusses issues relevant to clinical microbiology laboratories, hospital infection control, and antimicrobial stewardship efforts.

摘要

已在全球范围内成为一种具有多重耐药性的与医疗保健相关的真菌病原体。最近的报告强调了由于生物体鉴定错误、抗真菌药物耐药率高以及患者死亡率高而持续存在的挑战。种内和种间在医疗保健机构内传播的倾向可能是由促进皮肤定植和环境持久性的毒力因子所促进的,这在真菌中是独特的。本综述详细介绍了的全球出现情况,并讨论了与临床微生物学实验室、医院感染控制和抗菌药物管理工作相关的问题。